Newsletter 2014.07 – ANVISA publishes resolutions on new procedures relative to marketing authorization in Brazil: RDC #58 and #60/2014
The main law regulating the health system in Brazil – Law #6,360 dated 1976 – establishes that each and every drug available in the pharmaceutical market must be approved by the Ministry of Health. Since the creation of the Brazilian FDA (called ANVISA), this autonomous autarchy subordinated to the Ministry of Health is in charge of issuing marketing authorization for drugs for human use and of establishing specific resolutions in order to regulate each of the existing categories of medicaments, such as the new drugs, generics, similars, biologicals.
According to ANVISA’s requirements, the documentation submitted by the manufacturers of both generic and similar drugs, upon applying for marketing approval, is significantly simplified compared to the reference product (the so-called “abridged process”), as only pharmaceutical equivalence and relative bioavailability/ bioequivalence assays are required to obtain approval for products pertaining to these categories.
It should be noted that, since the publication of Resolutions RDC #133 (new applications for marketing approval) and RDC #134 (similars, already approved), both dated May 29, 2003, ANVISA has begun to require proof of therapeutic equivalence also for similar drugs; therefore, it is estimated that all manufacturers of these products will have complied with such requirement by the end of 2014.
Accordingly, studies of pharmaceutical equivalence and bioavailability/bioequivalence became necessary in order to obtain marketing authorization for both generic and similar drugs, although the latter were not then yet considered to be interchangeable with the reference product.
Last related news
September 13, 2023
New subject codes for filing applications for GMP certification for biological products industries
Last Friday, September 9th, the Brazilian FDA (ANVISA) published and made available new subject codes for submitting requests related to the Good … New subject codes for filing applications for GMP certification for biological products industries
September 13, 2023
BPTO publishes the 2nd ed. of the Industrial Designs Manual
By means of Ordinance INPI/PR Nr. 36 of September 6, 2023, published on September 12, 2023, the Brazilian PTO has published the … BPTO publishes the 2nd ed. of the Industrial Designs Manual
August 30, 2023
Approval of the Budapest Treaty moves forward in Brazil for International Recognition of the Deposit of Microorganism.
The approval of the Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purposes of Patent Procedure moves … Approval of the Budapest Treaty moves forward in Brazil for International Recognition of the Deposit of Microorganism.